J. V. Hervás-García

Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double‐blind, non‐inferiority trial

L. Ramió-Torrentá, Y. Blanco, A. Cano-Orgaz, 2018, European journal of neurology.

Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients

S. Presas-Rodríguez, A. Teniente-Serra, C. Ramo-Tello, 2018, CNS neuroscience & therapeutics.

Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients

E. Martínez-Cáceres, A. Cano-Orgaz, S. Presas-Rodríguez, 2018, Cytometry. Part B, Clinical cytometry.

Monitoring CD 49 d Receptor Occupancy : A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis patients Running Head : Monitoring and Optimizing Natalizumab Therapy

E. Martínez-Cáceres, A. Cano-Orgaz, S. Presas-Rodríguez, 2017 .

Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment

E. Martínez-Cáceres, S. Presas-Rodríguez, C. Ramo-Tello, 2019, Mediators of inflammation.

Gadolinium-enhanced brain lesions in multiple sclerosis relapse.

À. Rovira, M. Tintoré, Y. Blanco, 2021, Neurologia.

Myelitis: Differences between multiple sclerosis and other aetiologies.

S. Presas-Rodríguez, C. Ramo-Tello, L. Grau-López, 2016, Neurologia.

Multiple Intracranial Arteriovenous Fistulas in Cowden Syndrome.

J. Munuera, C. Castaño, C. Garcia-Esperon, 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Toxic hepatitis after concomitant interferon beta and aloe vera treatment in a patient with multiple sclerosis: A case report.

E. Montané, C. Ramo-Tello, J. V. Hervás-García, 2017, Neurologia.